영업이익률 악화 (5.9% → -5.7%, -11.7%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Astro Med financial statements
NASDAQ:ALOT · NasdaqAstro Med's published financial data is dated 2026-10-04. 2025 revenue was $151M. 2025 operating profit was −$9M.
Reported results
Financial safety
Reference indicatorAs of 2025- Altman Z''
- 3.27
- Beneish M-Score
- -3.30
- Sloan accrual
- -13.28%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
Piotroski measures year-over-year financial improvement, not absolute quality.
Profitability
- Positive ROANot passed
- Positive OCFPass
- Improving ΔROANot passed
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioNot passed
- No new sharesNot passed
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- -5.7%
- Interest coverage
- -2.7x
- Return on equity (ROE)
- -19.1%
Operating margin −5pp
Operating lossRevenue −15%
Interest coverage riskInterest rate +2pp
Interest coverage riskInterest coverage limit
Already below the limit by 7.8ppInterest coverage limit at an operating margin of 2.1%
Interest expense coverage threshold